40 GHP Q3 2024 AquaClinical, a boutique Clinical Research Organisation (CRO), focuses primarily on the study start-up phase of clinical trials. This includes sourcing suitable sites and investigators, as well as gathering the necessary information for ethical review and MHRA approval. The company prides itself on its consistent impact and is dedicated to providing clients with a smooth study start-up experience. AquaClinical’s commitment and transparency have earned it widespread praise and recognition. This, in turn, has earned AquaClinical the recognition of Global Health & Pharma, and we explore how this entity has earned itself the title of Boutique CRO of the Year 2024 – UK. AquaClinical is dedicated to helping clients take their first crucial steps in submitting clinical trials. As a customer-centric company, its impressive track record in rapid study preparation and insightful expertise has broadened the industry’s horizons. Despite its small size, the consultancy has embraced a grand vision, tirelessly working to bring it to life with integrity and client focus. AquaClinical takes immense pride in the impact of its services, often expressing that there is no greater joy than playing a part in changing treatment pathways for conditions with previously limited options. Thanks to the AquaClinical team’s extensive expertise in study startup activities and ethical submissions, the company has become the preferred choice for clients seeking swift yet ethical approvals. The company has secured numerous approvals across the UK, with the fastest study prepared in just four weeks, and activated 70 sites. This demonstrates its commitment to excellence. AquaClinical ensures the highest quality of services, emphasizing transparency and reliability. Clients can rely on its experts for support, knowing their best interests are always prioritized. AquaClinical frequently collaborates with small pharmaceutical and biotechnology companies, offering a uniquely tailored experience to its clients. This bespoke approach is highly valued by clients, as it combines pragmatism with honesty, especially when challenges arise. This creates realistic expectations while still meeting the needs of each client. From beginning to end, AquaClinical maintains transparency and open communication, ensuring an experience that not only meets client needs but also empowers and engages them throughout the process. To truly showcase the remarkable impact of AquaClinical, we turn to the words of one client, Dorota Poklonska: “Jay is extremely knowledgeable in regulatory aspects of the UK requirements. She is engaged and proactive, thinking outside the box as routine. She is also a great personality that makes her desired person to work with and rely on. Jay will be very professional and collegial addition to any team she works with.” It’s clear from the testimonials that AquaClinical is a reliable CRO, deeply invested in its impact. The organization is fully dedicated to maintaining its overwhelmingly positive influence on the industry. For this reason, Global Health & Pharma is thrilled to award AquaClinical the title of Boutique CRO of the Year 2024 – UK. We hope this recognition will further propel AquaClinical on its path to becoming the UK’s leading choice for study start-up services. Contact: Jay Tatla Company: AquaClinical Web Address: https://aquaclinical.com/ Innovating Health, One Trial at a Time
RkJQdWJsaXNoZXIy MTUyMDQwMA==